Webcast Alert: Ceragenix Pharmaceuticals, Inc. Presentation at Informed Investors Biotechnology, Healthcare, Pharmaceuticals Investor Forum to be Webcast on Thursday, August 25, 2005, 12:30 pm ET

DENVER, Aug. 24, 2005 -- Ceragenix Pharmaceuticals, Inc. (CGXP) will present at the following forum:

What: Ceragenix Pharmaceuticals, Inc. (CGXP) will give a presentation at Informed Investors Biotechnology, Healthcare, Pharmaceuticals On-line Investors Forum.

The keynote presentation will be from Dr. Adam K. Noah, Research Analyst with Granite Financial Group

When: August 25, 2005 @12:30 PM Eastern Time

Where: http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89493

How: Live over the Internet -- Simply log on to the web at the address above.

Contact: Steven Porter, Chief Executive Officer, sporter@ceragenix.com, (720)946-6440.

If you are unable to attend the live event, the forum will be archived and available via the Informed Investors website at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89493

Ceragenix is a development-stage biopharmaceutical company focused on dermatology and infectious disease. Ceragenix's patented Barrier Repair Technology, invented by Dr. Peter Elias and licensed from the University of California, is the platform for the development of two prescription topical creams -- EpiCeram(TM) and NeoCeram(TM) -- that form human-identical skin barriers. Defects in the skin's barrier function play critical roles in the pathogenesis of skin diseases such as eczema, irritant contact dermatitis, and other common skin disorders. The Company's patented Cationic Steroid Antibiotic (CSA) technology provides the basis for its novel antimicrobial medical device coating that may be attached to various medical devices to provide potentially long duration antimicrobial activity. Ceragenix also plans to develop CSAs for use as topical and systemic antibiotic therapies in the treatment of skin infections (MRSA), burn wound infections, eye infections, and other indications.

Contacts:

Informed Investors
Cary Loeser
804-327-3407
cloeser@wilink.com
www.informedinvestors.com